Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

MOMENTUM 3 Trial

Publications and Presentations

MOMENTUM 3 5-Year Outcomes

Momentum 3 5-Year Outcomes

This study examines outcomes from the 5-year extended analysis of the MOMENTUM 3 trial, comparing HeartMate 3™ LVAD to HeartMate II™ LVAD

5-year Survival with LVAD Therapy in MOMENTUM 3
 

Mehra, MR. 5-Year Survival with LVAD Therapy in MOMENTUM 3. Presented at: European Society of Cardiology (ESC) Annual Meeting; August 28, 2022; Barcelona, Spain.

This extension of the MOMENTUM 3 study extended out 5 years and showed the superior treatment effect of the HeartMate 3 LVAD over HeartMate II LVAD on HRAEs, which was associated with improved survival at 5-years:

  • Improved survival was driven by a reduction in hemocompatibility-related deaths, e.g. thrombosis, stroke, and bleeding
  • This study demonstrates that median survival with the HM3 reliably exceeds 5 years, even in those patients with refractory heart failure who are ineligible for transplantation
View Article
Download Presentation

MAT-2210315 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-1900882 v12.0